Pegylated Interferon Lambda Treatment for COVID-19
Status:
Terminated
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
Prospective randomized trial to assess the antiviral efficacy of Pegylated Interferon Lambda
(180 mcg SC injection) vs.placebo in up to 20 subjects with COVID-19 infection.